Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Diabetes Mellitus, Type 1

Trial Information

Islet Transplantation Alone (ITA) in Patients with Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

You have been asked to participate in this research study because you have difficult to control type 1 diabetes mellitus without kidney failure. Difficult to control type 1 diabetes is defined as wide swings in blood glucose that disrupt the patient’s life and result in frequent episodes of low blood glucose despite the proper use of standard insulin therapy and frequent blood glucose monitoring. The purpose of this study is to evaluate the safety and effectiveness of islet cell transplantation alone (ITA) in this disease. If you are selected, your participation for treatment on this study is expected to last 24 months. You will also require medical follow-up for the rest of your life.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.